Form 4: H.B. Fuller Executive James J. East Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President of H.B. Fuller, James J. East, reports acquisition and disposal of company stock and derivative securities on April 8, 2024.
Summary
- On April 8, 2024, James J. East, Executive Vice President of H.B. Fuller, reported transactions involving the company's stock and derivative securities.
- These transactions included the acquisition of common stock through the exercise of employee stock options at various prices, ranging from $48.35 to $72.94.
- East also disposed of 3,510 shares at a weighted average price of $78.315 and 18,806 shares at a weighted average price of $78.2565.
- Following these transactions, East directly owns 18,806 shares of common stock and indirectly owns 103.35 shares through a 401(k) plan.
- He also holds various employee stock options and restricted stock units.
- A correction was made to prior beneficial ownership reports, removing 5,828 shares of common stock that were inadvertently included.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. There is no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the executive's holdings and trading activity in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the executive's holdings.
- The report provides transparency to stakeholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 01/24/2021 | Date of employee stock option grant (Right-to-Buy) with exercise price of $48.35 |
| 01/27/2022 | Date of employee stock option grant (Right-to-Buy) with exercise price of $51.89 |
| 01/24/2023 | Date of employee stock option grant (Right-to-Buy) with exercise price of $72.94 and vesting start date for restricted stock units |
| 01/24/2024 | Date of employee stock option grant (Right-to-Buy) with exercise price of $68.17 and vesting start date for restricted stock units |
| 01/26/2025 | Date of employee stock option grant (Right-to-Buy) with exercise price of $77.72 and vesting start date for restricted stock units |
| 01/24/2025 | Expiration date for restricted stock units |
| 01/24/2026 | Expiration date for restricted stock units |
| 01/26/2027 | Expiration date for restricted stock units |
| 01/24/2030 | Expiration date for employee stock option (Right-to-Buy) with exercise price of $48.35 |
| 01/27/2031 | Expiration date for employee stock option (Right-to-Buy) with exercise price of $51.89 |
| 01/24/2032 | Expiration date for employee stock option (Right-to-Buy) with exercise price of $72.94 |
| 01/24/2033 | Expiration date for employee stock option (Right-to-Buy) with exercise price of $68.17 |
| 01/26/2034 | Expiration date for employee stock option (Right-to-Buy) with exercise price of $77.72 |
| 04/08/2024 | Date of reported transactions: stock option exercises and stock sales. |
| 04/10/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.